Synergy Asset Management’s AbbVie ABBV Stock Holding History

Synergy Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.3M	Buy	180,179 +157,767	+704%	+$33.9M	4.27%	3
2026 Q1	$4.87M	Sell	22,412 -78,267	-78%	-$17.4M	0.52%	43
2025 Q4	$23M	Sell	100,679 -10,070	-9%	-$2.29M	2.39%	12
2025 Q3	$25.6M	Buy	110,749 +90,852	+457%	+$18.5M	0.93%	26
2025 Q2	$3.69M	Buy	19,897 +9,738	+96%	+$1.81M	0.42%	44
2025 Q1	$2.13M	Buy	10,159 +1,378	+16%	+$268K	0.27%	63
2024 Q4	$1.58M	Buy	+8,781	New	+$1.61M	0.12%	97
2024 Q3	–	Sell	-17,035	Closed	-$2.92M	–	141
2024 Q2	$2.92M	Buy	+17,035	New	+$2.82M	0.46%	50
2022 Q4	–	Sell	-18,487	Closed	-$2.48M	–	107
2022 Q3	$2.48M	Buy	18,487 +4,331	+31%	+$621K	0.67%	40
2022 Q2	$2.17M	Buy	+14,156	New	+$2.16M	0.57%	46
2021 Q3	–	Sell	-12,020	Closed	-$1.35M	–	95
2021 Q2	$1.35M	Sell	12,020 -16,504	-58%	-$1.86M	0.36%	57
2021 Q1	$3.09M	Sell	28,524 -2,023	-7%	-$216K	0.92%	34
2020 Q4	$3.27M	Buy	+30,547	New	+$2.94M	1.03%	37

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Synergy Asset Management's ABBV Position: Q2 2026 in Review

Synergy Asset Management increased its AbbVie (ABBV) stake by 704% in Q2 2026, buying an estimated $33.9M and bringing the position to 180,179 shares worth $45.3M. The position accounts for 4.27% of the portfolio, ranked #3.

Synergy Asset Management first reported a position in ABBV in Q4 2020 and has held it in 13 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Synergy Asset Management held 180,179 shares of AbbVie worth $45.3M as of Q2 2026.
Synergy Asset Management bought 157,767 AbbVie shares in Q2 2026, an estimated $33.9M.
AbbVie made up 4.27% of Synergy Asset Management's portfolio in Q2 2026, its #3 holding.
Synergy Asset Management first reported a position in AbbVie in Q4 2020 and has held it in 13 quarters since.
4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Synergy Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.